Sylvant
Payments companies reported to CMS as associated with Sylvant. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Sylvant, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Sylvant
These are the largest totals companies reported as associated with Sylvant. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Corey Casper | Seattle, WA | Infectious Disease | $73,308.87 |
| Amit Mehta | Cary, NC | Hematology & Oncology | $41,033.85 |
| Frits Van Rhee | Little Rock, AR | Hematology & Oncology | $39,936.00 |
| Imran Siddiqi | Los Angeles, CA | Hematology (Pathology) | $37,128.28 |
| Gordon Srkalovic | Lansing, MI | Hematology & Oncology | $32,954.69 |
| Jadee Neff | Durham, NC | Hematology (Pathology) | $26,464.03 |
| Sudipto Mukherjee | Royal Oak, MI | Internal Medicine | $23,740.74 |
| Gaurav Goyal | Birmingham, AL | Hematology & Oncology | $17,387.12 |
| George Yaghmour | Los Angeles, CA | Hematology & Oncology | $16,440.50 |
| Fuad Shihab | Salt Lake City, UT | Nephrology (Internal Medicine) | $15,660.00 |
Prescribed Sylvant?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.